Tenet Healthcare (THC) PT Raised to $160 at Deutsche Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Dell shares surge on record AI server bookings
- 'No panic anywhere' may be the problem, BofA strategists warn
- Kroger cuts same-store sales outlook, keeps earnings guidance
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Tenet Healthcare (THC) PT Raised to $170 at Mizuho
July 29, 2024 7:14 AM EDTMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.
The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More
Tenet Healthcare (THC) PT Raised to $170 at Mizuho
July 26, 2024 1:55 PM EDTMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.
The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More
Tenet Healthcare (THC) PT Raised to $171 at Citi
July 24, 2024 4:47 PM EDTCiti analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $171.00 (from $139.00) while maintaining a Buy rating.
The analyst comments "2Q24 EBITDA of $945M ($915 ex retro TX) was ahead of expectations, driven by strength in USPI rev/case, hospital volume... More
Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance
July 24, 2024 6:50 AM EDTTenet Healthcare (NYSE: THC) reported Q2 EPS of $2.31, $0.41 better than the analyst estimate of $1.90. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $4.99 billion.
GUIDANCE:
Tenet Healthcare sees Q3 2024 EPS of $2.16-$2.58, versus the consensus of... More
